Home
About Us
Company Culture
Milestones
Awards and Honors
Social Responsibility
Talent Development
Hot
Recombinant Protein Product
Research and Innovation
R&D Team
Pipelines
Product Category
Drug Products
Peginterferon Alfa-2b Injection
Pegsomatropin Injection
Pegfilgrastim Injection
Molgramostim
Filgrastim
Oprelvekin
API
Reagents
Growth Factors
Interleukins
Interferons
Enzymes
Others
News
Contact Us
English
简体中文
Home
/
News
News and Events
Amoytop Biotech Awarded National-level "Individual Champion Enterprise in Manufacturing Industry"
2026
01-29
Read More
The Development Path of the Biomedical Industry: From Seed to Forest
2025
12-18
Read More
People's Daily Health Client Side: From Treatment to Cure —— China's Prevention and Control of Hepatitis B Has Entered a New Era of Functional Cure
2025
10-29
Read More
Peginterferon alfa-2b (Pegbing®) Received Marketing Authorization for New Indication: Combined with Nucleos(t)ide Analogues for HBsAg Sustained Clearance in Adult Patients with Chronic Hepatitis B.
2025
10-13
Read More
1
2
3
4
...
11
»
Facebook
Twitter
LinkedIn
Instagram
WELCOME
Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Fax: +86-592-6889110
international@amoytop.com
Tel: +86-592-6889106
Copyright ©
2023
Amoytop Biotech All Rights Reserved. Support by
Leadong
｜
Sitemap
.
Privacy Policy
Email
international@amoytop.com
reagent@amoytop.com
Tel
+86-592-6889106
cell Phone
+86-18060918257
Leave a Message
Get In Touch
Submit
